Price movement over the last 24 hours
AdaptHealth Corp vs Seagate Technology Holdings PLC — how do they compare? AdaptHealth Corp trades at $10.05 (market cap $1.38B), while Seagate Technology Holdings PLC trades at $832.71 (market cap $187.26B). The key difference: Seagate Technology Holdings PLC is far larger — about 135.7× AdaptHealth Corp's market cap, and Seagate Technology Holdings PLC pays a 0.36% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | STX | |
|---|---|---|
Market Cap | $1.38B | $187.26B |
Sector | Health | Technology |
52-Week High | $13.38 | $1.09K |
52-Week Low | $8.68 | $142.01 |
Enterprise Value | $3.33B | $190.29B |
Dividend Yield | — | 0.36% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
STX trades at $827.64, up 0.91% today, with a bearish technical signal and neutral oscillators. The stock shows strong fundamental momentum, with Q1 2026 EPS of $4.10 beating expectations of $3.51, continuing a trend of earnings beats. Revenue for 2025 reached $9.10 billion with a net income margin of 21.6%, while valuation ratios like P/E of 82.38 and P/B of 179.4 reflect high growth expectations. Recent news highlights STX as a top momentum stock amid AI-driven demand, despite sector volatility.
The outlook for STX is positive, driven by robust earnings growth and AI infrastructure demand, with a consensus price target of $955.71 implying 15% upside. Risks include high debt levels, with a debt-to-asset ratio of 73.31% in 2024, and sensitivity to memory market fluctuations, as seen in recent sell-offs. Investor sentiment remains bullish among analysts, with 51% buy ratings, but technical weakness warrants caution near-term.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →